在学术医疗中心临床实施针对个性化医疗的预防性药物基因组学测试
Bani Tamraz1,2, Jaekyu Shin1, Raman Khanna1
1University of California, San Francisco, San Francisco, CA 94143, United States.
Journal of the American Medical Informatics Association : JAMIA
|December 12, 2024
概括
UCSF Health实施了与临床决策支持 (CDS) 集成的预防性药物基因组学 (PGx) 测试,为临床医生提供可操作的遗传洞察力,用于精确的药物管理.
科学领域:
- 遗传学 是一个遗传学.
- 药理学 药理学是指药理学的学科.
- 临床信息学 临床信息学
背景情况:
- 临床药物基因组学 (PGx) 将遗传信息整合到患者护理中,以优化药物治疗.
- 将PGx整合到常规临床实践中需要强大的测试和决策支持系统.
- 一个主要的学术医疗中心UCSF Health试图实施一个先发制人的PGx计划.
研究的目的:
- 描述预防性临床药物基因组学测试的实施.
- 详细介绍一个自动化临床决策支持 (CDS) 系统的集成,用于在护理点提供PGx信息.
- 为了提高UCSF健康的临床医生的药物决策.
主要方法:
- 一个多学科团队开发了PGx计划策略,确定了关键的药物基因相互作用和可操作的等位基因.
- 选择并验证了一个基因型识别平台,并根据HIPAA指南将结果电子转移到电子健康记录 (EHR).
- 临床决策支持 (CDS) 已开发并与电子处方系统集成.
主要成果:
- 建立了一个定制的PGx程序,涵盖56种药物和15种基因.
- 该系统将233个药物遗传学处方警报和15个测试提示纳入了EHR,所有这些都是临床医生批准的.
- 可操作的临床PGx信息在护理点向临床医生提供.
结论:
- 多学科团队成功实施了预防性PGx测试.
- 整合PGx测试与临床医疗点CDS可以提高临床医生准确的药物决策.
- 这一举措展示了在学术医疗中心预防性药物基因组学的成功模式.
相关概念视频
Combination Therapies and Personalized Medicine
4.8K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.8K
Analysis of Population Pharmacokinetic Data
232
Analysis of population pharmacokinetic data involves studying the behavior of drugs within diverse populations to understand their pharmacokinetic parameters. Traditional pharmacokinetic methods typically involve collecting samples from a few individuals and estimating these parameters. While these methods are commonly used, they have limitations in capturing the variability in drug response among individuals or heterogeneous populations. Population pharmacokinetics is employed to address these...
232
Preclinical Development: Overview
4.2K
Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
4.2K
Human Genetics
534
Human genetics provides a profound framework for understanding the interplay between genetic predispositions and human psychology. At the heart of this discipline lies the study of how genes influence physical traits, behaviors, and susceptibility to diseases. Each person carries a unique genetic code that subtly or significantly shapes their psychological and behavioral landscape.
The complex relationship between genetics and psychology is observable through common biological components such...
The complex relationship between genetics and psychology is observable through common biological components such...
534


